Health Condition 1: G809- Cerebral palsy, unspecified Health Condition 2: S349- Injury of unspecified nerves at abdomen, lower back and pelvis level Health Condition 3: G710- Muscular dystrophy
Conditions
Interventions
Intervention1: Autologous Bone Marrow-Derived Mononuclear Cell Fraction: The posterior iliac crest is often where bone marrow is collected under either local or general anesthesia for the aspiration p
Sponsors
Anchal Aggarwal
Eligibility
Inclusion criteria
Inclusion criteria: Patients with established clinical diagnosis of Cerebral Palsy, Spinal cord injury, Muscular dystrophy or other neurological disorders for whom there were no proven interventions available or if available had been ineffective
Exclusion criteria
Exclusion criteria: Patients with organic brain disorders, Hydrocephalus, CNS Infection, space occupying lesions Presence of acute infections such as HIV/HBV/ HCV; malignancies, and any other medical conditions such as respiratory infection, cardiac conditions Patients who are unlikely to adhere to follow-up visits or those who cannot commit to the required follow-up duration Patients not giving consent for procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the safety and to assess the efficacy of autologous bone marrow-derived mononuclear cell therapy in improving neurological function. Timepoint: 0, 3, 6, 9, 12 and 15 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the impact of therapy on quality of life in patients with neurological disorders. Timepoint: 0, 3, 6, 9, 12 and 15 months | — |
Countries
India
Contacts
Public ContactAnchal Aggarwal
L.L.R. Hospital and G.S.V.M. Medical College
Outcome results
None listed